High Power Laser and Particle Beams, Volume. 34, Issue 8, 084007(2022)

Cold test and beam commissioning of China’s first homemade alternating-phase-focused drift tube linac

Xiucui Xie1, Yuehu Pu1,2、*, and Zhentang Zhao3
Author Affiliations
  • 1Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
  • 2Shanghai APACTRON Particle Equipment Co. Ltd, Shanghai 201800, China
  • 3Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201204, China
  • show less

    Linac injector is a major sub-system of the proton therapy facility. Due to schedule consideration, the Shanghai advance proton therapy facility APTRON uses a linac injector made by ACCSYS in California, USA. Now, we have developed a linac injector made up of Electron Cyclotron Resonance (ECR) ion source and 4-vane Radio Frequency Quadrupole (RFQ), as well as alternating-phase-focused (APF) Drift Tube Linac (DTL), which is a significant technological innovation. During the last 5 years, we have finished a series of R&D stage including physical design, electromagnetic design, mechanical design, assembly and alignment, cavity cold test, RF conditioning and beam commissioning. Finally, we get 7 mA, 7 MeV proton beam from the down stream Faraday cup. According to the measurement of our beam diagnostic and analysis system, the center energy of the beam is 6.975 MeV, the beam intensity within ±0.35% momentum spread is 6.07 mA.

    Tools

    Get Citation

    Copy Citation Text

    Xiucui Xie, Yuehu Pu, Zhentang Zhao. Cold test and beam commissioning of China’s first homemade alternating-phase-focused drift tube linac[J]. High Power Laser and Particle Beams, 2022, 34(8): 084007

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category: Particle Beams and Accelerator Technology

    Received: Jan. 6, 2022

    Accepted: Apr. 11, 2022

    Published Online: Aug. 8, 2022

    The Author Email: Yuehu Pu (puyuehu@sinap.ac.cn)

    DOI:10.11884/HPLPB202234.220014

    Topics